Evidence map›Paper›PMID 41199308›Full record

ArticleParticle and fibre toxicology2025

Fabrication of microplastic and nanoplastic particles and fibres for use in pulmonary toxicity studies.

Eric Auyang, Mengzheng Ouyang, Adam Laycock, Henry Blake, Teresa D Tetley, Timothy W Gant, Anne E Willis, Stephanie Wright

Abstract read
In one paragraph

Article in Particle and fibre toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eric AuyangMRC Centre for Environmental and Health, Environmental Research Group, School of Public Health, Faculty of Medicine, Imperial College London, London, W12 0BZ, UK. eric.auyang19@imperial.ac.uk.
Mengzheng OuyangDepartment of Earth Science and Engineering, Imperial College London, London, SW7 2AZ, UK.
Adam LaycockHPRU in Environmental Exposures and Health. Toxicology Department, Radiation, Chemical and Environmental Hazards Directorate, UK Health Security Agency, Harwell Campus, Oxfordshire, OX11 0RQ, UK.
Henry BlakeMRC Centre for Environmental and Health, Environmental Research Group, School of Public Health, Faculty of Medicine, Imperial College London, London, W12 0BZ, UK.
Teresa D TetleyLung Cell Biology, Airways Disease, National Heart & Lung Institute, Imperial College London, London, W12 0HS, UK.
Timothy W GantHPRU in Environmental Exposures and Health. Toxicology Department, Radiation, Chemical and Environmental Hazards Directorate, UK Health Security Agency, Harwell Campus, Oxfordshire, OX11 0RQ, UK.
Anne E WillisMRC Toxicology Unit, Cambridge University, Tennis Court Road, Cambridge, CB2 1QW, UK.
Stephanie WrightMRC Centre for Environmental and Health, Environmental Research Group, School of Public Health, Faculty of Medicine, Imperial College London, London, W12 0BZ, UK. s.wright19@imperial.ac.uk.

Funding

National Institute for Health and Care Research NIHR-INF-1830UK Research and Innovation MC_PC_20044
6 · The paper itself

Abstract

backgroundMicro/nanoplastics (MNPs) are a commonly detected environmental contaminant in indoor and outdoor environments. Airborne MNPs are of various shapes and sizes, some of which are small enough to reach the deep lung if inhaled. Current research into the toxicity of airborne MNPs in the lung has only involved a small number of polymers and shapes due to their limited availability. The most commonly available are polystyrene spheres and to date, these have been used in the majority of studies, though their relevance to environmental MNPs is limited. To address this gap, we aimed to develop a method to fabricate MNPs of three environmentally relevant polymers, producing both micro- and nano-sized particles as well as fibres. Enhancing the consistency and accessibility of test materials will enable researchers to better investigate how size, shape, and polymer type influence lung toxicity, while also reducing variability introduced during fabrication.

resultsWe successfully developed methods to fabricate MNPs of polyamide, polystyrene, and polyethylene terephthalate, as microplastics, nanoplastics, and fibres. MNPs were characterized for their chemical purity and size. The size of the fabricated MNPs were found to be of a respirable dimension. As a solvent-based method of preparation was used, leachates from the MNPs were analysed to check for contamination that could cause non-specific toxicity. These were found to have no effect on the metabolic activity of either THP-1 macrophages or transformed type-1 (TT1) epithelial cells.

conclusionsThis work provides pulmonary toxicologists with a method for the fabrication of MNPs and their physical and chemical characteristics. Their characteristics indicate they are a representative test material for experimental systems.

Indexed as

LungMicroplasticsNanoparticlesCell SurvivalHumansNylonsParticle SizePolystyrenesToxicity TestsMicroplasticsNylonsPolystyrenesHazard assessmentMicroplastic fibresMicroplasticsNanoplasticsPulmonary toxicologyTest materials

Identifiers

PMID41199308
PMCPMC12590796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.